Temporary importation of 0.9% Sodium Chloride Injection from Sichuan Kelun Pharmaceutical Co., Ltd. (Kelun) to assist in mitigating drug shortages in the U.S.

To prevent a shortage of large volume parenteral fluid drug products, Kelun is coordinating with the U.S. Food and Drug Administration (FDA), to temporarily import 0.9% Sodium Chloride Injection (250 mL) from Kelun’s manufacturing facility in Chengdu, China.

The Dear Healthcare Provider (DHCP) letter has been provided below and contains important product information.

Please contact ApiJect Systems Corp., the U.S. importer of Kelun's product (Tel: 855-826-4885) for more information.